Echosens Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Echosens's estimated annual revenue is currently $85.3M per year.(i)
  • Echosens's estimated revenue per employee is $251,000

Employee Data

  • Echosens has 340 Employees.(i)
  • Echosens grew their employee count by 5% last year.

Echosens's People

NameTitleEmail/Phone
1
CEO (CEO), North AmericaReveal Email/Phone
2
Commercial VPReveal Email/Phone
3
VP Engineering and OperationsReveal Email/Phone
4
VP, PharmaReveal Email/Phone
5
VP Sales, North AmericaReveal Email/Phone
6
Chairman and Chief Technology OfficerReveal Email/Phone
7
Global Director Commercial OperationsReveal Email/Phone
8
Marketing DirectorReveal Email/Phone
9
Director Service and Integration.Reveal Email/Phone
10
Chief Marketing OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.6M1269%N/AN/A
#2
$65.8M2623%N/AN/A
#3
$55.7M22247%N/AN/A
#4
$43.4M173-9%N/AN/A
#5
$32.4M1295%N/AN/A
#6
$115M4589%N/AN/A
#7
$36.4M1459%N/AN/A
#8
$143.7M409-11%€83.1MN/A
#9
$32.4M1292%N/AN/A
#10
$2571.2M102444%N/AN/A
Add Company

What Is Echosens?

Empowering medical professionals to assess, diagnose and manage chronic liver diseases, everywhere, for simpler, faster and better patient care and liver health. In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ for liver stiffness assessment, and CAP™ for steatosis quantification. FibroScan® device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,400 medical publications and 40 guidelines recommendations. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.

keywords:N/A

N/A

Total Funding

340

Number of Employees

$85.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Echosens News

2022-04-17 - Transient Elastography Devices Market Size, Outlook And ...

Echosens, Sandhill Scientific. This comprehensive Transient Elastography Devices Market report helps in determining the deficiencies and...

2022-03-30 - Echosens Supports American Minority Health Month in April ...

Echosens Supports American Minority Health Month in April, Highlights Need for Early Liver Disease Detection Among Hispanic Groups.

2022-03-22 - Transient Elastography Device Market with Leading ...

The top players in recombinant ingredient market are Echosens and Sandhill Scientific, Inc. The report covers exhaustive analysis on: Market...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$87.4M341-11%N/A
#2
$140.6M34332%N/A
#3
$7.5M34323%N/A
#4
N/A3437%N/A
#5
$94.3M3439%N/A